282 related articles for article (PubMed ID: 36096979)
1. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.
Tea V; Morelle JF; Gallet R; Cayla G; Lemesle G; Lhermusier T; Dillinger JG; Ducrocq G; Angouvant D; Cottin Y; Chamandi C; le Bras A; Steg PG; Montalescot G; Nelson AC; Simon T; Chatellier G; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2022 Oct; 115(10):496-504. PubMed ID: 36096979
[TBL] [Abstract][Full Text] [Related]
2. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
[TBL] [Abstract][Full Text] [Related]
3. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
[TBL] [Abstract][Full Text] [Related]
4. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
5. Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction.
Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; Ngaleu Siaha F; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; Djadi-Prat J; Chatellier G; Danchin N;
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013913. PubMed ID: 38785084
[TBL] [Abstract][Full Text] [Related]
6. Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.
Stähli BE; Varbella F; Linke A; Schwarz B; Felix SB; Seiffert M; Kesterke R; Nordbeck P; Witzenbichler B; Lang IM; Kessler M; Valina C; Dibra A; Rohla M; Moccetti M; Vercellino M; Gaede L; Bott-Flügel L; Jakob P; Stehli J; Candreva A; Templin C; Schindler M; Wischnewsky M; Zanda G; Quadri G; Mangner N; Toma A; Magnani G; Clemmensen P; Lüscher TF; Münzel T; Schulze PC; Laugwitz KL; Rottbauer W; Huber K; Neumann FJ; Schneider S; Weidinger F; Achenbach S; Richardt G; Kastrati A; Ford I; Maier W; Ruschitzka F;
N Engl J Med; 2023 Oct; 389(15):1368-1379. PubMed ID: 37634190
[TBL] [Abstract][Full Text] [Related]
7. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y;
Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031
[TBL] [Abstract][Full Text] [Related]
8. Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
Park S; Rha SW; Choi BG; Cho JH; Park SH; Lee JB; Kim YH; Park SM; Choi JW; Park JY; Shin ES; Lee JB; Suh J; Chae JK; Choi YJ; Jeong MH; Cha KS; Lee SW; Kim U; Kim GC; Choi WG; Cho YH; Cho DK; Ahn J; Suh SY; Choi SY; Byun JK; Cha JA; Hyun SJ; Kim JB; Choi CU; Park CG
Am Heart J; 2023 May; 259():58-67. PubMed ID: 36754106
[TBL] [Abstract][Full Text] [Related]
9. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Am J Cardiol; 2019 Aug; 124(3):334-342. PubMed ID: 31174834
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J
Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818
[TBL] [Abstract][Full Text] [Related]
12. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
Lee JM; Kim HK; Park KH; Choo EH; Kim CJ; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
Eur Heart J; 2023 Feb; 44(6):473-484. PubMed ID: 36540034
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
[TBL] [Abstract][Full Text] [Related]
14. Complete revascularization based on angiography derived fractional flow reserve versus incomplete revascularization in patients with ST-segment elevation myocardial infarction.
Liu J; Zhang K; Wang X; Liu Z; Chen M; Fan F; Jia J; Hong T; Li J; Huo Y; Gong Y; Zheng B
Cardiol J; 2024; 31(2):226-234. PubMed ID: 37772351
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
[TBL] [Abstract][Full Text] [Related]
16. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; De Bruyne B; Chatellier G; Danchin N;
N Engl J Med; 2021 Jul; 385(4):297-308. PubMed ID: 33999545
[TBL] [Abstract][Full Text] [Related]
17. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Diletti R; den Dekker WK; Bennett J; Schotborgh CE; van der Schaaf R; Sabaté M; Moreno R; Ameloot K; van Bommel R; Forlani D; van Reet B; Esposito G; Dirksen MT; Ruifrok WPT; Everaert BRC; Van Mieghem C; Elscot JJ; Cummins P; Lenzen M; Brugaletta S; Boersma E; Van Mieghem NM;
Lancet; 2023 Apr; 401(10383):1172-1182. PubMed ID: 36889333
[TBL] [Abstract][Full Text] [Related]
18. Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.
Ahmad Y; Howard JP; Arnold A; Prasad M; Seligman H; Cook CM; Warisawa T; Shun-Shun M; Ali Z; Parikh MA; Al-Lamee R; Sen S; Francis D; Moses JW; Leon MB; Stone GW; Karmpaliotis D
J Am Heart Assoc; 2020 Jun; 9(12):e015263. PubMed ID: 32476540
[TBL] [Abstract][Full Text] [Related]
19. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
Böhm F; Mogensen B; Engstrøm T; Stankovic G; Srdanovic I; Lønborg J; Zwackman S; Hamid M; Kellerth T; Lauermann J; Kajander OA; Andersson J; Linder R; Angerås O; Renlund H; Ērglis A; Menon M; Schultz C; Laine M; Held C; Rück A; Östlund O; James S;
N Engl J Med; 2024 Apr; 390(16):1481-1492. PubMed ID: 38587995
[TBL] [Abstract][Full Text] [Related]
20. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
